The 2013 Site Solutions Summit features Pearl Pathways’ own Diana Caldwell. She will be involved in the roundtable discussions as a panelist and moderator for topics such as: Investigator Insider: What your site needs to know about your next potential investigator;...
Our office will be closed for the holidays December 24th, 25th, 31st and also on January 1st. There will be no IRB Board meeting the week of December 24th due to the holidays. We will resume IRB reviews the week of December 31st and hold a Board meeting on January...
Our office will be closed for the holidays November 22 through November 23, 2012. There will be no board meeting on the 22nd, but will resume normal schedule the week of the 26th. If you need to talk to us about your need for an urgent review, just contact us and we...
Our Board will still meet the holiday week of 4th of July. Please submit all documents and forms by end of day July 3rd for review in the July 12, 2012 regularly scheduled meeting. To discuss your upcoming study review needs, contact us at 317.899.9341 or email...
In the last 5 years, big pharma has continued its move toward large molecules and biologics for drug development. Two recent studies from Withers & Rogers (a UK law firm specializing in IP) and KMR Group (a pharma consultancy) report on some of the trends among...
In the wake of the recent commotion surrounding flawed research at Duke University on diagnostic tools based on molecular patterns (“omics” tests), an Institute of Medicine (IOM) panel has issued a report entitled Evolution of Translational Omics: Lessons Learned and...
